nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Daunorubicin—hematologic cancer	0.0416	0.0686	CbGbCtD
Argatroban—CYP3A5—Thalidomide—hematologic cancer	0.0379	0.0624	CbGbCtD
Argatroban—CYP3A5—Teniposide—hematologic cancer	0.0361	0.0596	CbGbCtD
Argatroban—CYP3A5—Ifosfamide—hematologic cancer	0.0333	0.055	CbGbCtD
Argatroban—CYP3A5—Imatinib—hematologic cancer	0.0318	0.0525	CbGbCtD
Argatroban—CYP3A4—Bexarotene—hematologic cancer	0.0276	0.0456	CbGbCtD
Argatroban—CYP3A4—Lomustine—hematologic cancer	0.0257	0.0424	CbGbCtD
Argatroban—CYP3A4—Busulfan—hematologic cancer	0.0257	0.0424	CbGbCtD
Argatroban—CYP3A5—Dasatinib—hematologic cancer	0.0256	0.0422	CbGbCtD
Argatroban—CYP3A4—Thiotepa—hematologic cancer	0.0229	0.0378	CbGbCtD
Argatroban—CYP3A5—Irinotecan—hematologic cancer	0.0199	0.0328	CbGbCtD
Argatroban—CYP3A4—Methoxsalen—hematologic cancer	0.0178	0.0294	CbGbCtD
Argatroban—CYP3A5—Vincristine—hematologic cancer	0.0174	0.0287	CbGbCtD
Argatroban—CYP3A4—Bortezomib—hematologic cancer	0.0169	0.0279	CbGbCtD
Argatroban—CYP3A4—Daunorubicin—hematologic cancer	0.0162	0.0267	CbGbCtD
Argatroban—CYP3A5—Etoposide—hematologic cancer	0.0159	0.0263	CbGbCtD
Argatroban—CYP3A4—Cytarabine—hematologic cancer	0.0143	0.0236	CbGbCtD
Argatroban—CYP3A4—Teniposide—hematologic cancer	0.0141	0.0232	CbGbCtD
Argatroban—CYP3A5—Dexamethasone—hematologic cancer	0.0131	0.0216	CbGbCtD
Argatroban—CYP3A4—Ifosfamide—hematologic cancer	0.013	0.0214	CbGbCtD
Argatroban—CYP3A4—Imatinib—hematologic cancer	0.0124	0.0205	CbGbCtD
Argatroban—CYP3A4—Ruxolitinib—hematologic cancer	0.0117	0.0193	CbGbCtD
Argatroban—CYP3A4—Nilotinib—hematologic cancer	0.0113	0.0186	CbGbCtD
Argatroban—CYP3A4—Vinorelbine—hematologic cancer	0.0112	0.0185	CbGbCtD
Argatroban—CYP3A4—Triamcinolone—hematologic cancer	0.0102	0.0169	CbGbCtD
Argatroban—CYP3A4—Dasatinib—hematologic cancer	0.00997	0.0164	CbGbCtD
Argatroban—CYP3A4—Mitoxantrone—hematologic cancer	0.00985	0.0162	CbGbCtD
Argatroban—CYP3A4—Betamethasone—hematologic cancer	0.00878	0.0145	CbGbCtD
Argatroban—CYP3A4—Prednisolone—hematologic cancer	0.00866	0.0143	CbGbCtD
Argatroban—CYP3A4—Prednisone—hematologic cancer	0.00818	0.0135	CbGbCtD
Argatroban—CYP3A4—Irinotecan—hematologic cancer	0.00775	0.0128	CbGbCtD
Argatroban—CYP3A4—Vinblastine—hematologic cancer	0.00689	0.0114	CbGbCtD
Argatroban—CYP3A4—Vincristine—hematologic cancer	0.00678	0.0112	CbGbCtD
Argatroban—CYP3A4—Etoposide—hematologic cancer	0.00621	0.0102	CbGbCtD
Argatroban—CYP3A4—Dexamethasone—hematologic cancer	0.00511	0.00842	CbGbCtD
Argatroban—CYP3A4—Doxorubicin—hematologic cancer	0.00424	0.00699	CbGbCtD
Argatroban—Angiopathy—Prednisone—hematologic cancer	7.54e-05	0.000256	CcSEcCtD
Argatroban—Headache—Vinorelbine—hematologic cancer	7.53e-05	0.000255	CcSEcCtD
Argatroban—Hypersensitivity—Vincristine—hematologic cancer	7.49e-05	0.000254	CcSEcCtD
Argatroban—Infection—Triamcinolone—hematologic cancer	7.43e-05	0.000252	CcSEcCtD
Argatroban—Feeling abnormal—Cisplatin—hematologic cancer	7.41e-05	0.000251	CcSEcCtD
Argatroban—Haematuria—Methotrexate—hematologic cancer	7.38e-05	0.00025	CcSEcCtD
Argatroban—Dyspnoea—Etoposide—hematologic cancer	7.35e-05	0.000249	CcSEcCtD
Argatroban—Dizziness—Thalidomide—hematologic cancer	7.34e-05	0.000249	CcSEcCtD
Argatroban—Angina pectoris—Doxorubicin—hematologic cancer	7.32e-05	0.000248	CcSEcCtD
Argatroban—Nausea—Bortezomib—hematologic cancer	7.31e-05	0.000248	CcSEcCtD
Argatroban—Hypersensitivity—Irinotecan—hematologic cancer	7.3e-05	0.000247	CcSEcCtD
Argatroban—Hypersensitivity—Mitoxantrone—hematologic cancer	7.3e-05	0.000247	CcSEcCtD
Argatroban—Tachycardia—Triamcinolone—hematologic cancer	7.29e-05	0.000247	CcSEcCtD
Argatroban—Vomiting—Thiotepa—hematologic cancer	7.29e-05	0.000247	CcSEcCtD
Argatroban—Diarrhoea—Carmustine—hematologic cancer	7.29e-05	0.000247	CcSEcCtD
Argatroban—Pneumonia—Epirubicin—hematologic cancer	7.28e-05	0.000247	CcSEcCtD
Argatroban—Nausea—Bleomycin—hematologic cancer	7.25e-05	0.000246	CcSEcCtD
Argatroban—Rash—Thiotepa—hematologic cancer	7.23e-05	0.000245	CcSEcCtD
Argatroban—Dermatitis—Thiotepa—hematologic cancer	7.23e-05	0.000245	CcSEcCtD
Argatroban—Diarrhoea—Alitretinoin—hematologic cancer	7.22e-05	0.000245	CcSEcCtD
Argatroban—Headache—Thiotepa—hematologic cancer	7.19e-05	0.000244	CcSEcCtD
Argatroban—Diarrhoea—Ifosfamide—hematologic cancer	7.14e-05	0.000242	CcSEcCtD
Argatroban—Nausea—Vinorelbine—hematologic cancer	7.14e-05	0.000242	CcSEcCtD
Argatroban—Gastrointestinal disorder—Etoposide—hematologic cancer	7.11e-05	0.000241	CcSEcCtD
Argatroban—Body temperature increased—Cisplatin—hematologic cancer	7.11e-05	0.000241	CcSEcCtD
Argatroban—Vomiting—Thalidomide—hematologic cancer	7.05e-05	0.000239	CcSEcCtD
Argatroban—Dizziness—Carmustine—hematologic cancer	7.05e-05	0.000239	CcSEcCtD
Argatroban—Constipation—Etoposide—hematologic cancer	7.05e-05	0.000239	CcSEcCtD
Argatroban—Pain—Etoposide—hematologic cancer	7.05e-05	0.000239	CcSEcCtD
Argatroban—Urinary tract infection—Epirubicin—hematologic cancer	7.04e-05	0.000239	CcSEcCtD
Argatroban—Rash—Thalidomide—hematologic cancer	7e-05	0.000237	CcSEcCtD
Argatroban—Dermatitis—Thalidomide—hematologic cancer	6.99e-05	0.000237	CcSEcCtD
Argatroban—Haemoglobin—Methotrexate—hematologic cancer	6.98e-05	0.000237	CcSEcCtD
Argatroban—Dizziness—Alitretinoin—hematologic cancer	6.98e-05	0.000237	CcSEcCtD
Argatroban—Diarrhoea—Vincristine—hematologic cancer	6.96e-05	0.000236	CcSEcCtD
Argatroban—Headache—Thalidomide—hematologic cancer	6.95e-05	0.000236	CcSEcCtD
Argatroban—Pain—Prednisolone—hematologic cancer	6.95e-05	0.000236	CcSEcCtD
Argatroban—Haemorrhage—Methotrexate—hematologic cancer	6.95e-05	0.000236	CcSEcCtD
Argatroban—Haematuria—Epirubicin—hematologic cancer	6.91e-05	0.000234	CcSEcCtD
Argatroban—Dizziness—Ifosfamide—hematologic cancer	6.9e-05	0.000234	CcSEcCtD
Argatroban—Nausea—Thiotepa—hematologic cancer	6.81e-05	0.000231	CcSEcCtD
Argatroban—Feeling abnormal—Etoposide—hematologic cancer	6.79e-05	0.00023	CcSEcCtD
Argatroban—Diarrhoea—Irinotecan—hematologic cancer	6.78e-05	0.00023	CcSEcCtD
Argatroban—Diarrhoea—Mitoxantrone—hematologic cancer	6.78e-05	0.00023	CcSEcCtD
Argatroban—Vomiting—Carmustine—hematologic cancer	6.78e-05	0.00023	CcSEcCtD
Argatroban—Pneumonia—Doxorubicin—hematologic cancer	6.74e-05	0.000229	CcSEcCtD
Argatroban—Gastrointestinal pain—Etoposide—hematologic cancer	6.74e-05	0.000228	CcSEcCtD
Argatroban—Infection—Betamethasone—hematologic cancer	6.74e-05	0.000228	CcSEcCtD
Argatroban—Infection—Dexamethasone—hematologic cancer	6.74e-05	0.000228	CcSEcCtD
Argatroban—Dizziness—Vincristine—hematologic cancer	6.73e-05	0.000228	CcSEcCtD
Argatroban—Rash—Carmustine—hematologic cancer	6.72e-05	0.000228	CcSEcCtD
Argatroban—Dermatitis—Carmustine—hematologic cancer	6.71e-05	0.000228	CcSEcCtD
Argatroban—Vomiting—Alitretinoin—hematologic cancer	6.71e-05	0.000228	CcSEcCtD
Argatroban—Feeling abnormal—Prednisolone—hematologic cancer	6.7e-05	0.000227	CcSEcCtD
Argatroban—Headache—Carmustine—hematologic cancer	6.68e-05	0.000226	CcSEcCtD
Argatroban—Dyspnoea—Triamcinolone—hematologic cancer	6.66e-05	0.000226	CcSEcCtD
Argatroban—Rash—Alitretinoin—hematologic cancer	6.66e-05	0.000226	CcSEcCtD
Argatroban—Dermatitis—Alitretinoin—hematologic cancer	6.65e-05	0.000225	CcSEcCtD
Argatroban—Vomiting—Ifosfamide—hematologic cancer	6.63e-05	0.000225	CcSEcCtD
Argatroban—Hypersensitivity—Cisplatin—hematologic cancer	6.63e-05	0.000225	CcSEcCtD
Argatroban—Tachycardia—Dexamethasone—hematologic cancer	6.62e-05	0.000224	CcSEcCtD
Argatroban—Tachycardia—Betamethasone—hematologic cancer	6.62e-05	0.000224	CcSEcCtD
Argatroban—Bradycardia—Epirubicin—hematologic cancer	6.62e-05	0.000224	CcSEcCtD
Argatroban—Headache—Alitretinoin—hematologic cancer	6.61e-05	0.000224	CcSEcCtD
Argatroban—Diarrhoea—Gemcitabine—hematologic cancer	6.6e-05	0.000224	CcSEcCtD
Argatroban—Nausea—Thalidomide—hematologic cancer	6.59e-05	0.000223	CcSEcCtD
Argatroban—Dyspepsia—Triamcinolone—hematologic cancer	6.58e-05	0.000223	CcSEcCtD
Argatroban—Rash—Ifosfamide—hematologic cancer	6.58e-05	0.000223	CcSEcCtD
Argatroban—Dermatitis—Ifosfamide—hematologic cancer	6.57e-05	0.000223	CcSEcCtD
Argatroban—Dizziness—Irinotecan—hematologic cancer	6.55e-05	0.000222	CcSEcCtD
Argatroban—Haemoglobin—Epirubicin—hematologic cancer	6.53e-05	0.000222	CcSEcCtD
Argatroban—Abdominal pain—Etoposide—hematologic cancer	6.51e-05	0.000221	CcSEcCtD
Argatroban—Body temperature increased—Etoposide—hematologic cancer	6.51e-05	0.000221	CcSEcCtD
Argatroban—Urinary tract infection—Doxorubicin—hematologic cancer	6.51e-05	0.000221	CcSEcCtD
Argatroban—Haemorrhage—Epirubicin—hematologic cancer	6.5e-05	0.00022	CcSEcCtD
Argatroban—Vomiting—Vincristine—hematologic cancer	6.47e-05	0.000219	CcSEcCtD
Argatroban—Rash—Vincristine—hematologic cancer	6.41e-05	0.000217	CcSEcCtD
Argatroban—Dermatitis—Vincristine—hematologic cancer	6.41e-05	0.000217	CcSEcCtD
Argatroban—Pain—Triamcinolone—hematologic cancer	6.39e-05	0.000217	CcSEcCtD
Argatroban—Haematuria—Doxorubicin—hematologic cancer	6.39e-05	0.000217	CcSEcCtD
Argatroban—Headache—Vincristine—hematologic cancer	6.37e-05	0.000216	CcSEcCtD
Argatroban—Hypotension—Betamethasone—hematologic cancer	6.34e-05	0.000215	CcSEcCtD
Argatroban—Hypotension—Dexamethasone—hematologic cancer	6.34e-05	0.000215	CcSEcCtD
Argatroban—Nausea—Carmustine—hematologic cancer	6.33e-05	0.000215	CcSEcCtD
Argatroban—Angiopathy—Methotrexate—hematologic cancer	6.3e-05	0.000214	CcSEcCtD
Argatroban—Vomiting—Mitoxantrone—hematologic cancer	6.3e-05	0.000214	CcSEcCtD
Argatroban—Vomiting—Irinotecan—hematologic cancer	6.3e-05	0.000214	CcSEcCtD
Argatroban—Nausea—Alitretinoin—hematologic cancer	6.27e-05	0.000213	CcSEcCtD
Argatroban—Rash—Irinotecan—hematologic cancer	6.25e-05	0.000212	CcSEcCtD
Argatroban—Rash—Mitoxantrone—hematologic cancer	6.25e-05	0.000212	CcSEcCtD
Argatroban—Dermatitis—Irinotecan—hematologic cancer	6.24e-05	0.000212	CcSEcCtD
Argatroban—Dermatitis—Mitoxantrone—hematologic cancer	6.24e-05	0.000212	CcSEcCtD
Argatroban—Headache—Irinotecan—hematologic cancer	6.21e-05	0.00021	CcSEcCtD
Argatroban—Headache—Mitoxantrone—hematologic cancer	6.21e-05	0.00021	CcSEcCtD
Argatroban—Nausea—Ifosfamide—hematologic cancer	6.2e-05	0.00021	CcSEcCtD
Argatroban—Feeling abnormal—Triamcinolone—hematologic cancer	6.16e-05	0.000209	CcSEcCtD
Argatroban—Diarrhoea—Cisplatin—hematologic cancer	6.15e-05	0.000209	CcSEcCtD
Argatroban—Vomiting—Gemcitabine—hematologic cancer	6.14e-05	0.000208	CcSEcCtD
Argatroban—Bradycardia—Doxorubicin—hematologic cancer	6.12e-05	0.000208	CcSEcCtD
Argatroban—Rash—Gemcitabine—hematologic cancer	6.08e-05	0.000206	CcSEcCtD
Argatroban—Dermatitis—Gemcitabine—hematologic cancer	6.08e-05	0.000206	CcSEcCtD
Argatroban—Hypersensitivity—Etoposide—hematologic cancer	6.07e-05	0.000206	CcSEcCtD
Argatroban—Haemoglobin—Doxorubicin—hematologic cancer	6.05e-05	0.000205	CcSEcCtD
Argatroban—Headache—Gemcitabine—hematologic cancer	6.05e-05	0.000205	CcSEcCtD
Argatroban—Nausea—Vincristine—hematologic cancer	6.04e-05	0.000205	CcSEcCtD
Argatroban—Haemorrhage—Doxorubicin—hematologic cancer	6.02e-05	0.000204	CcSEcCtD
Argatroban—Hypersensitivity—Prednisolone—hematologic cancer	5.99e-05	0.000203	CcSEcCtD
Argatroban—Dyspepsia—Dexamethasone—hematologic cancer	5.97e-05	0.000202	CcSEcCtD
Argatroban—Dyspepsia—Betamethasone—hematologic cancer	5.97e-05	0.000202	CcSEcCtD
Argatroban—Body temperature increased—Triamcinolone—hematologic cancer	5.91e-05	0.0002	CcSEcCtD
Argatroban—Angiopathy—Epirubicin—hematologic cancer	5.9e-05	0.0002	CcSEcCtD
Argatroban—Nausea—Irinotecan—hematologic cancer	5.88e-05	0.0002	CcSEcCtD
Argatroban—Nausea—Mitoxantrone—hematologic cancer	5.88e-05	0.0002	CcSEcCtD
Argatroban—Infection—Prednisone—hematologic cancer	5.87e-05	0.000199	CcSEcCtD
Argatroban—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.86e-05	0.000199	CcSEcCtD
Argatroban—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.86e-05	0.000199	CcSEcCtD
Argatroban—Back pain—Methotrexate—hematologic cancer	5.85e-05	0.000198	CcSEcCtD
Argatroban—Pain—Betamethasone—hematologic cancer	5.8e-05	0.000197	CcSEcCtD
Argatroban—Pain—Dexamethasone—hematologic cancer	5.8e-05	0.000197	CcSEcCtD
Argatroban—Tachycardia—Prednisone—hematologic cancer	5.76e-05	0.000195	CcSEcCtD
Argatroban—Nausea—Gemcitabine—hematologic cancer	5.73e-05	0.000194	CcSEcCtD
Argatroban—Vomiting—Cisplatin—hematologic cancer	5.72e-05	0.000194	CcSEcCtD
Argatroban—Rash—Cisplatin—hematologic cancer	5.67e-05	0.000192	CcSEcCtD
Argatroban—Dermatitis—Cisplatin—hematologic cancer	5.67e-05	0.000192	CcSEcCtD
Argatroban—Diarrhoea—Etoposide—hematologic cancer	5.64e-05	0.000191	CcSEcCtD
Argatroban—Feeling abnormal—Betamethasone—hematologic cancer	5.59e-05	0.000189	CcSEcCtD
Argatroban—Feeling abnormal—Dexamethasone—hematologic cancer	5.59e-05	0.000189	CcSEcCtD
Argatroban—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.55e-05	0.000188	CcSEcCtD
Argatroban—Gastrointestinal pain—Betamethasone—hematologic cancer	5.55e-05	0.000188	CcSEcCtD
Argatroban—Hypersensitivity—Triamcinolone—hematologic cancer	5.51e-05	0.000187	CcSEcCtD
Argatroban—Back pain—Epirubicin—hematologic cancer	5.47e-05	0.000186	CcSEcCtD
Argatroban—Angiopathy—Doxorubicin—hematologic cancer	5.46e-05	0.000185	CcSEcCtD
Argatroban—Dizziness—Etoposide—hematologic cancer	5.45e-05	0.000185	CcSEcCtD
Argatroban—Dizziness—Prednisolone—hematologic cancer	5.37e-05	0.000182	CcSEcCtD
Argatroban—Body temperature increased—Betamethasone—hematologic cancer	5.36e-05	0.000182	CcSEcCtD
Argatroban—Abdominal pain—Dexamethasone—hematologic cancer	5.36e-05	0.000182	CcSEcCtD
Argatroban—Body temperature increased—Dexamethasone—hematologic cancer	5.36e-05	0.000182	CcSEcCtD
Argatroban—Abdominal pain—Betamethasone—hematologic cancer	5.36e-05	0.000182	CcSEcCtD
Argatroban—Nausea—Cisplatin—hematologic cancer	5.34e-05	0.000181	CcSEcCtD
Argatroban—Cough—Methotrexate—hematologic cancer	5.28e-05	0.000179	CcSEcCtD
Argatroban—Vomiting—Etoposide—hematologic cancer	5.24e-05	0.000178	CcSEcCtD
Argatroban—Dyspepsia—Prednisone—hematologic cancer	5.2e-05	0.000176	CcSEcCtD
Argatroban—Rash—Etoposide—hematologic cancer	5.2e-05	0.000176	CcSEcCtD
Argatroban—Dermatitis—Etoposide—hematologic cancer	5.19e-05	0.000176	CcSEcCtD
Argatroban—Headache—Etoposide—hematologic cancer	5.16e-05	0.000175	CcSEcCtD
Argatroban—Chest pain—Methotrexate—hematologic cancer	5.15e-05	0.000175	CcSEcCtD
Argatroban—Rash—Prednisolone—hematologic cancer	5.12e-05	0.000174	CcSEcCtD
Argatroban—Dermatitis—Prednisolone—hematologic cancer	5.12e-05	0.000174	CcSEcCtD
Argatroban—Headache—Prednisolone—hematologic cancer	5.09e-05	0.000173	CcSEcCtD
Argatroban—Back pain—Doxorubicin—hematologic cancer	5.07e-05	0.000172	CcSEcCtD
Argatroban—Constipation—Prednisone—hematologic cancer	5.05e-05	0.000171	CcSEcCtD
Argatroban—Confusional state—Methotrexate—hematologic cancer	4.98e-05	0.000169	CcSEcCtD
Argatroban—Dizziness—Triamcinolone—hematologic cancer	4.94e-05	0.000168	CcSEcCtD
Argatroban—Cough—Epirubicin—hematologic cancer	4.94e-05	0.000167	CcSEcCtD
Argatroban—Infection—Methotrexate—hematologic cancer	4.9e-05	0.000166	CcSEcCtD
Argatroban—Nausea—Etoposide—hematologic cancer	4.89e-05	0.000166	CcSEcCtD
Argatroban—Feeling abnormal—Prednisone—hematologic cancer	4.87e-05	0.000165	CcSEcCtD
Argatroban—Gastrointestinal pain—Prednisone—hematologic cancer	4.83e-05	0.000164	CcSEcCtD
Argatroban—Nausea—Prednisolone—hematologic cancer	4.83e-05	0.000164	CcSEcCtD
Argatroban—Chest pain—Epirubicin—hematologic cancer	4.82e-05	0.000163	CcSEcCtD
Argatroban—Vomiting—Triamcinolone—hematologic cancer	4.75e-05	0.000161	CcSEcCtD
Argatroban—Rash—Triamcinolone—hematologic cancer	4.71e-05	0.00016	CcSEcCtD
Argatroban—Dermatitis—Triamcinolone—hematologic cancer	4.71e-05	0.00016	CcSEcCtD
Argatroban—Headache—Triamcinolone—hematologic cancer	4.68e-05	0.000159	CcSEcCtD
Argatroban—Abdominal pain—Prednisone—hematologic cancer	4.67e-05	0.000158	CcSEcCtD
Argatroban—Body temperature increased—Prednisone—hematologic cancer	4.67e-05	0.000158	CcSEcCtD
Argatroban—Confusional state—Epirubicin—hematologic cancer	4.66e-05	0.000158	CcSEcCtD
Argatroban—Diarrhoea—Betamethasone—hematologic cancer	4.64e-05	0.000157	CcSEcCtD
Argatroban—Diarrhoea—Dexamethasone—hematologic cancer	4.64e-05	0.000157	CcSEcCtD
Argatroban—Hypotension—Methotrexate—hematologic cancer	4.61e-05	0.000156	CcSEcCtD
Argatroban—Infection—Epirubicin—hematologic cancer	4.59e-05	0.000156	CcSEcCtD
Argatroban—Cough—Doxorubicin—hematologic cancer	4.57e-05	0.000155	CcSEcCtD
Argatroban—Tachycardia—Epirubicin—hematologic cancer	4.51e-05	0.000153	CcSEcCtD
Argatroban—Dizziness—Dexamethasone—hematologic cancer	4.48e-05	0.000152	CcSEcCtD
Argatroban—Dizziness—Betamethasone—hematologic cancer	4.48e-05	0.000152	CcSEcCtD
Argatroban—Chest pain—Doxorubicin—hematologic cancer	4.46e-05	0.000151	CcSEcCtD
Argatroban—Nausea—Triamcinolone—hematologic cancer	4.44e-05	0.000151	CcSEcCtD
Argatroban—Dyspnoea—Methotrexate—hematologic cancer	4.4e-05	0.000149	CcSEcCtD
Argatroban—Hypersensitivity—Prednisone—hematologic cancer	4.35e-05	0.000148	CcSEcCtD
Argatroban—Dyspepsia—Methotrexate—hematologic cancer	4.34e-05	0.000147	CcSEcCtD
Argatroban—Hypotension—Epirubicin—hematologic cancer	4.32e-05	0.000146	CcSEcCtD
Argatroban—Vomiting—Dexamethasone—hematologic cancer	4.31e-05	0.000146	CcSEcCtD
Argatroban—Vomiting—Betamethasone—hematologic cancer	4.31e-05	0.000146	CcSEcCtD
Argatroban—Confusional state—Doxorubicin—hematologic cancer	4.31e-05	0.000146	CcSEcCtD
Argatroban—Rash—Betamethasone—hematologic cancer	4.28e-05	0.000145	CcSEcCtD
Argatroban—Rash—Dexamethasone—hematologic cancer	4.28e-05	0.000145	CcSEcCtD
Argatroban—Dermatitis—Dexamethasone—hematologic cancer	4.27e-05	0.000145	CcSEcCtD
Argatroban—Dermatitis—Betamethasone—hematologic cancer	4.27e-05	0.000145	CcSEcCtD
Argatroban—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.26e-05	0.000144	CcSEcCtD
Argatroban—Headache—Betamethasone—hematologic cancer	4.25e-05	0.000144	CcSEcCtD
Argatroban—Headache—Dexamethasone—hematologic cancer	4.25e-05	0.000144	CcSEcCtD
Argatroban—Infection—Doxorubicin—hematologic cancer	4.25e-05	0.000144	CcSEcCtD
Argatroban—Pain—Methotrexate—hematologic cancer	4.22e-05	0.000143	CcSEcCtD
Argatroban—Tachycardia—Doxorubicin—hematologic cancer	4.17e-05	0.000141	CcSEcCtD
Argatroban—Dyspnoea—Epirubicin—hematologic cancer	4.12e-05	0.00014	CcSEcCtD
Argatroban—Feeling abnormal—Methotrexate—hematologic cancer	4.07e-05	0.000138	CcSEcCtD
Argatroban—Dyspepsia—Epirubicin—hematologic cancer	4.07e-05	0.000138	CcSEcCtD
Argatroban—Diarrhoea—Prednisone—hematologic cancer	4.04e-05	0.000137	CcSEcCtD
Argatroban—Gastrointestinal pain—Methotrexate—hematologic cancer	4.04e-05	0.000137	CcSEcCtD
Argatroban—Nausea—Betamethasone—hematologic cancer	4.03e-05	0.000137	CcSEcCtD
Argatroban—Nausea—Dexamethasone—hematologic cancer	4.03e-05	0.000137	CcSEcCtD
Argatroban—Hypotension—Doxorubicin—hematologic cancer	3.99e-05	0.000135	CcSEcCtD
Argatroban—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.99e-05	0.000135	CcSEcCtD
Argatroban—Constipation—Epirubicin—hematologic cancer	3.95e-05	0.000134	CcSEcCtD
Argatroban—Pain—Epirubicin—hematologic cancer	3.95e-05	0.000134	CcSEcCtD
Argatroban—Dizziness—Prednisone—hematologic cancer	3.91e-05	0.000132	CcSEcCtD
Argatroban—Body temperature increased—Methotrexate—hematologic cancer	3.9e-05	0.000132	CcSEcCtD
Argatroban—Abdominal pain—Methotrexate—hematologic cancer	3.9e-05	0.000132	CcSEcCtD
Argatroban—Dyspnoea—Doxorubicin—hematologic cancer	3.81e-05	0.000129	CcSEcCtD
Argatroban—Feeling abnormal—Epirubicin—hematologic cancer	3.81e-05	0.000129	CcSEcCtD
Argatroban—Gastrointestinal pain—Epirubicin—hematologic cancer	3.78e-05	0.000128	CcSEcCtD
Argatroban—Dyspepsia—Doxorubicin—hematologic cancer	3.76e-05	0.000128	CcSEcCtD
Argatroban—Vomiting—Prednisone—hematologic cancer	3.76e-05	0.000127	CcSEcCtD
Argatroban—Rash—Prednisone—hematologic cancer	3.72e-05	0.000126	CcSEcCtD
Argatroban—Dermatitis—Prednisone—hematologic cancer	3.72e-05	0.000126	CcSEcCtD
Argatroban—Headache—Prednisone—hematologic cancer	3.7e-05	0.000125	CcSEcCtD
Argatroban—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.69e-05	0.000125	CcSEcCtD
Argatroban—Pain—Doxorubicin—hematologic cancer	3.65e-05	0.000124	CcSEcCtD
Argatroban—Constipation—Doxorubicin—hematologic cancer	3.65e-05	0.000124	CcSEcCtD
Argatroban—Abdominal pain—Epirubicin—hematologic cancer	3.65e-05	0.000124	CcSEcCtD
Argatroban—Body temperature increased—Epirubicin—hematologic cancer	3.65e-05	0.000124	CcSEcCtD
Argatroban—Hypersensitivity—Methotrexate—hematologic cancer	3.64e-05	0.000123	CcSEcCtD
Argatroban—Feeling abnormal—Doxorubicin—hematologic cancer	3.52e-05	0.000119	CcSEcCtD
Argatroban—Nausea—Prednisone—hematologic cancer	3.51e-05	0.000119	CcSEcCtD
Argatroban—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.49e-05	0.000118	CcSEcCtD
Argatroban—Hypersensitivity—Epirubicin—hematologic cancer	3.4e-05	0.000115	CcSEcCtD
Argatroban—Body temperature increased—Doxorubicin—hematologic cancer	3.38e-05	0.000115	CcSEcCtD
Argatroban—Abdominal pain—Doxorubicin—hematologic cancer	3.38e-05	0.000115	CcSEcCtD
Argatroban—Diarrhoea—Methotrexate—hematologic cancer	3.38e-05	0.000115	CcSEcCtD
Argatroban—F2—Hemostasis—JAK2—hematologic cancer	3.33e-05	0.000337	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DKK1—hematologic cancer	3.32e-05	0.000336	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT5B—hematologic cancer	3.3e-05	0.000334	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC35B2—hematologic cancer	3.27e-05	0.000331	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GBA—hematologic cancer	3.27e-05	0.000331	CbGpPWpGaD
Argatroban—Dizziness—Methotrexate—hematologic cancer	3.26e-05	0.000111	CcSEcCtD
Argatroban—F2—Signaling Pathways—ADCY7—hematologic cancer	3.2e-05	0.000324	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CB—hematologic cancer	3.17e-05	0.00032	CbGpPWpGaD
Argatroban—Diarrhoea—Epirubicin—hematologic cancer	3.16e-05	0.000107	CcSEcCtD
Argatroban—F2—Signaling by GPCR—CSF2—hematologic cancer	3.16e-05	0.00032	CbGpPWpGaD
Argatroban—Hypersensitivity—Doxorubicin—hematologic cancer	3.15e-05	0.000107	CcSEcCtD
Argatroban—Vomiting—Methotrexate—hematologic cancer	3.14e-05	0.000106	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—IL2RA—hematologic cancer	3.13e-05	0.000317	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—XIAP—hematologic cancer	3.11e-05	0.000315	CbGpPWpGaD
Argatroban—Rash—Methotrexate—hematologic cancer	3.11e-05	0.000106	CcSEcCtD
Argatroban—Dermatitis—Methotrexate—hematologic cancer	3.11e-05	0.000105	CcSEcCtD
Argatroban—Headache—Methotrexate—hematologic cancer	3.09e-05	0.000105	CcSEcCtD
Argatroban—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	3.07e-05	0.000311	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.06e-05	0.00031	CbGpPWpGaD
Argatroban—Dizziness—Epirubicin—hematologic cancer	3.05e-05	0.000104	CcSEcCtD
Argatroban—F2—Signaling by GPCR—JAK1—hematologic cancer	3.05e-05	0.000309	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PRKCG—hematologic cancer	3.05e-05	0.000309	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SH2B3—hematologic cancer	3.03e-05	0.000307	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SMARCA4—hematologic cancer	3.03e-05	0.000307	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.03e-05	0.000307	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CCL2—hematologic cancer	3.03e-05	0.000306	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GZMB—hematologic cancer	3.01e-05	0.000305	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTAP—hematologic cancer	2.99e-05	0.000302	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNA1—hematologic cancer	2.94e-05	0.000298	CbGpPWpGaD
Argatroban—Vomiting—Epirubicin—hematologic cancer	2.94e-05	9.96e-05	CcSEcCtD
Argatroban—Nausea—Methotrexate—hematologic cancer	2.93e-05	9.94e-05	CcSEcCtD
Argatroban—F2—Signaling Pathways—HSPB1—hematologic cancer	2.93e-05	0.000296	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EIF4EBP1—hematologic cancer	2.93e-05	0.000296	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL3—hematologic cancer	2.93e-05	0.000296	CbGpPWpGaD
Argatroban—Diarrhoea—Doxorubicin—hematologic cancer	2.92e-05	9.91e-05	CcSEcCtD
Argatroban—Rash—Epirubicin—hematologic cancer	2.91e-05	9.87e-05	CcSEcCtD
Argatroban—Dermatitis—Epirubicin—hematologic cancer	2.91e-05	9.87e-05	CcSEcCtD
Argatroban—F2—Hemostasis—IL2—hematologic cancer	2.91e-05	0.000294	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTHLH—hematologic cancer	2.89e-05	0.000293	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SDC1—hematologic cancer	2.89e-05	0.000293	CbGpPWpGaD
Argatroban—Headache—Epirubicin—hematologic cancer	2.89e-05	9.81e-05	CcSEcCtD
Argatroban—F2—Signaling by GPCR—IL2RA—hematologic cancer	2.85e-05	0.000288	CbGpPWpGaD
Argatroban—Dizziness—Doxorubicin—hematologic cancer	2.83e-05	9.58e-05	CcSEcCtD
Argatroban—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.83e-05	0.000286	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTGER4—hematologic cancer	2.82e-05	0.000285	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LCK—hematologic cancer	2.8e-05	0.000284	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.79e-05	0.000282	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—H3F3A—hematologic cancer	2.75e-05	0.000278	CbGpPWpGaD
Argatroban—Nausea—Epirubicin—hematologic cancer	2.74e-05	9.3e-05	CcSEcCtD
Argatroban—Vomiting—Doxorubicin—hematologic cancer	2.72e-05	9.21e-05	CcSEcCtD
Argatroban—Rash—Doxorubicin—hematologic cancer	2.69e-05	9.14e-05	CcSEcCtD
Argatroban—Dermatitis—Doxorubicin—hematologic cancer	2.69e-05	9.13e-05	CcSEcCtD
Argatroban—Headache—Doxorubicin—hematologic cancer	2.68e-05	9.08e-05	CcSEcCtD
Argatroban—F2—Signaling Pathways—PRKCZ—hematologic cancer	2.67e-05	0.00027	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FHL2—hematologic cancer	2.66e-05	0.00027	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—hematologic cancer	2.61e-05	0.000264	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AGRN—hematologic cancer	2.61e-05	0.000264	CbGpPWpGaD
Argatroban—F2—Hemostasis—EP300—hematologic cancer	2.61e-05	0.000264	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PARP1—hematologic cancer	2.58e-05	0.000261	CbGpPWpGaD
Argatroban—Nausea—Doxorubicin—hematologic cancer	2.54e-05	8.61e-05	CcSEcCtD
Argatroban—F2—Signaling Pathways—FBXW7—hematologic cancer	2.54e-05	0.000257	CbGpPWpGaD
Argatroban—F2—Hemostasis—SRC—hematologic cancer	2.54e-05	0.000257	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HDAC2—hematologic cancer	2.49e-05	0.000252	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR4—hematologic cancer	2.49e-05	0.000252	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMMR—hematologic cancer	2.47e-05	0.000251	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—IDH2—hematologic cancer	2.47e-05	0.000251	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—hematologic cancer	2.47e-05	0.00025	CbGpPWpGaD
Argatroban—F2—Hemostasis—NRAS—hematologic cancer	2.44e-05	0.000247	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CBL—hematologic cancer	2.43e-05	0.000246	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL3—hematologic cancer	2.4e-05	0.000243	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—hematologic cancer	2.37e-05	0.00024	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTPN1—hematologic cancer	2.36e-05	0.000239	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FTCD—hematologic cancer	2.36e-05	0.000239	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GMPS—hematologic cancer	2.36e-05	0.000239	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PHYH—hematologic cancer	2.36e-05	0.000239	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK3—hematologic cancer	2.34e-05	0.000237	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTPN11—hematologic cancer	2.33e-05	0.000236	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ARNTL—hematologic cancer	2.33e-05	0.000236	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RASGRP1—hematologic cancer	2.32e-05	0.000235	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HSP90AA1—hematologic cancer	2.31e-05	0.000234	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SYK—hematologic cancer	2.31e-05	0.000234	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CD—hematologic cancer	2.29e-05	0.000232	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—hematologic cancer	2.27e-05	0.00023	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CA9—hematologic cancer	2.26e-05	0.000229	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ACP5—hematologic cancer	2.26e-05	0.000229	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CREB1—hematologic cancer	2.26e-05	0.000228	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOR2—hematologic cancer	2.23e-05	0.000226	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT1—hematologic cancer	2.23e-05	0.000226	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL2—hematologic cancer	2.21e-05	0.000224	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6R—hematologic cancer	2.2e-05	0.000223	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3R1—hematologic cancer	2.17e-05	0.000219	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.15e-05	0.000218	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—IDH1—hematologic cancer	2.13e-05	0.000215	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—JAK2—hematologic cancer	2.11e-05	0.000213	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCC3—hematologic cancer	2.1e-05	0.000213	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTO1—hematologic cancer	2.1e-05	0.000213	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TXN—hematologic cancer	2.1e-05	0.000213	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—hematologic cancer	2.1e-05	0.000213	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAP2K1—hematologic cancer	2.1e-05	0.000212	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRB2—hematologic cancer	2.09e-05	0.000211	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CD—hematologic cancer	2.08e-05	0.000211	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFA—hematologic cancer	2.08e-05	0.000211	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SPHK1—hematologic cancer	2.06e-05	0.000208	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KITLG—hematologic cancer	2.05e-05	0.000208	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT5A—hematologic cancer	2.01e-05	0.000203	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CB—hematologic cancer	2e-05	0.000203	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN2B—hematologic cancer	1.99e-05	0.000201	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.98e-05	0.0002	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3R1—hematologic cancer	1.97e-05	0.000199	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—hematologic cancer	1.93e-05	0.000195	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.92e-05	0.000195	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.92e-05	0.000195	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD86—hematologic cancer	1.92e-05	0.000195	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—JAK2—hematologic cancer	1.91e-05	0.000194	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HES1—hematologic cancer	1.9e-05	0.000192	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NCOR1—hematologic cancer	1.89e-05	0.000191	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DCK—hematologic cancer	1.88e-05	0.000191	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ASNS—hematologic cancer	1.88e-05	0.000191	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.88e-05	0.000191	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.88e-05	0.00019	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—hematologic cancer	1.87e-05	0.000189	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF1—hematologic cancer	1.86e-05	0.000189	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CSF2—hematologic cancer	1.86e-05	0.000189	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FOXO1—hematologic cancer	1.84e-05	0.000186	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—hematologic cancer	1.84e-05	0.000186	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFRB—hematologic cancer	1.83e-05	0.000186	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CB—hematologic cancer	1.82e-05	0.000184	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NUP98—hematologic cancer	1.82e-05	0.000184	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFRA—hematologic cancer	1.81e-05	0.000183	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAK1—hematologic cancer	1.8e-05	0.000182	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCG—hematologic cancer	1.8e-05	0.000182	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HDC—hematologic cancer	1.79e-05	0.000181	CbGpPWpGaD
Argatroban—F2—Hemostasis—HRAS—hematologic cancer	1.79e-05	0.000181	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ADCY7—hematologic cancer	1.76e-05	0.000179	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOA3—hematologic cancer	1.76e-05	0.000179	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NUP214—hematologic cancer	1.75e-05	0.000177	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTR—hematologic cancer	1.72e-05	0.000174	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCG2—hematologic cancer	1.72e-05	0.000174	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ENO2—hematologic cancer	1.68e-05	0.00017	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2RA—hematologic cancer	1.68e-05	0.00017	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—hematologic cancer	1.67e-05	0.000169	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TERT—hematologic cancer	1.66e-05	0.000168	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CDA—hematologic cancer	1.63e-05	0.000165	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTT1—hematologic cancer	1.63e-05	0.000165	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFB—hematologic cancer	1.62e-05	0.000164	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SDC1—hematologic cancer	1.59e-05	0.000161	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TSC2—hematologic cancer	1.59e-05	0.000161	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—hematologic cancer	1.58e-05	0.00016	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PC—hematologic cancer	1.57e-05	0.000159	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGFR3—hematologic cancer	1.53e-05	0.000154	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GBA—hematologic cancer	1.52e-05	0.000154	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.52e-05	0.000154	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK14—hematologic cancer	1.51e-05	0.000153	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ESR1—hematologic cancer	1.48e-05	0.00015	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FN1—hematologic cancer	1.46e-05	0.000148	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BAD—hematologic cancer	1.45e-05	0.000146	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKBIA—hematologic cancer	1.45e-05	0.000146	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH1—hematologic cancer	1.43e-05	0.000145	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD80—hematologic cancer	1.4e-05	0.000142	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—hematologic cancer	1.4e-05	0.000142	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KIT—hematologic cancer	1.4e-05	0.000142	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—NRAS—hematologic cancer	1.4e-05	0.000142	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTAP—hematologic cancer	1.39e-05	0.000141	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTPN11—hematologic cancer	1.38e-05	0.000139	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NQO1—hematologic cancer	1.36e-05	0.000137	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CD44—hematologic cancer	1.36e-05	0.000137	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK3—hematologic cancer	1.34e-05	0.000136	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CREB1—hematologic cancer	1.33e-05	0.000135	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BRAF—hematologic cancer	1.32e-05	0.000133	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL2—hematologic cancer	1.3e-05	0.000132	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6R—hematologic cancer	1.3e-05	0.000132	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CREBBP—hematologic cancer	1.3e-05	0.000131	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYCS—hematologic cancer	1.28e-05	0.00013	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	1.27e-05	0.000129	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAP2K1—hematologic cancer	1.24e-05	0.000125	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FHL2—hematologic cancer	1.24e-05	0.000125	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CD—hematologic cancer	1.23e-05	0.000125	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.22e-05	0.000123	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AGRN—hematologic cancer	1.21e-05	0.000123	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—hematologic cancer	1.21e-05	0.000122	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF2—hematologic cancer	1.18e-05	0.000119	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3R1—hematologic cancer	1.16e-05	0.000118	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—IDH2—hematologic cancer	1.15e-05	0.000116	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMMR—hematologic cancer	1.15e-05	0.000116	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.13e-05	0.000115	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAK2—hematologic cancer	1.13e-05	0.000114	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—hematologic cancer	1.11e-05	0.000112	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MDM2—hematologic cancer	1.1e-05	0.000112	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.08e-05	0.00011	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MTOR—hematologic cancer	1.07e-05	0.000109	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CB—hematologic cancer	1.07e-05	0.000109	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACP5—hematologic cancer	1.05e-05	0.000107	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CA9—hematologic cancer	1.05e-05	0.000107	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.04e-05	0.000105	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.04e-05	0.000105	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.04e-05	0.000105	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HRAS—hematologic cancer	1.02e-05	0.000104	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1B—hematologic cancer	1.01e-05	0.000102	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—hematologic cancer	9.96e-06	0.000101	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—IDH1—hematologic cancer	9.89e-06	0.0001	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—hematologic cancer	9.87e-06	9.99e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—hematologic cancer	9.86e-06	9.98e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—hematologic cancer	9.81e-06	9.93e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTO1—hematologic cancer	9.78e-06	9.9e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TXN—hematologic cancer	9.78e-06	9.9e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCC3—hematologic cancer	9.78e-06	9.9e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—hematologic cancer	9.61e-06	9.73e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JUN—hematologic cancer	9.59e-06	9.71e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SPHK1—hematologic cancer	9.57e-06	9.69e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1A—hematologic cancer	9.29e-06	9.41e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—hematologic cancer	9.27e-06	9.39e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UGT1A1—hematologic cancer	9.2e-06	9.31e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—hematologic cancer	9.18e-06	9.3e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK8—hematologic cancer	9.07e-06	9.18e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—hematologic cancer	9.05e-06	9.16e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC22A1—hematologic cancer	8.95e-06	9.06e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CRABP1—hematologic cancer	8.95e-06	9.06e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EP300—hematologic cancer	8.84e-06	8.95e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALOX5—hematologic cancer	8.72e-06	8.83e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SRC—hematologic cancer	8.6e-06	8.71e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NUP98—hematologic cancer	8.44e-06	8.55e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—hematologic cancer	8.38e-06	8.48e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—hematologic cancer	8.29e-06	8.4e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NRAS—hematologic cancer	8.27e-06	8.38e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ADCY7—hematologic cancer	8.2e-06	8.3e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOA3—hematologic cancer	8.2e-06	8.3e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NUP214—hematologic cancer	8.14e-06	8.24e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.97e-06	8.07e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTR—hematologic cancer	7.97e-06	8.07e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK3—hematologic cancer	7.92e-06	8.02e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ENO2—hematologic cancer	7.82e-06	7.92e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—hematologic cancer	7.72e-06	7.81e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—hematologic cancer	7.71e-06	7.8e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—hematologic cancer	7.69e-06	7.78e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTT1—hematologic cancer	7.58e-06	7.68e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SDC1—hematologic cancer	7.41e-06	7.51e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CREBBP—hematologic cancer	7.15e-06	7.24e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—hematologic cancer	7.12e-06	7.21e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CD—hematologic cancer	6.78e-06	6.87e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—hematologic cancer	6.7e-06	6.78e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—hematologic cancer	6.54e-06	6.62e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3R1—hematologic cancer	6.41e-06	6.49e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—hematologic cancer	6.33e-06	6.41e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CD44—hematologic cancer	6.3e-06	6.38e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NQO1—hematologic cancer	6.3e-06	6.38e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRAS—hematologic cancer	6.05e-06	6.13e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYCS—hematologic cancer	5.96e-06	6.04e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.93e-06	6e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CB—hematologic cancer	5.91e-06	5.99e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—hematologic cancer	5.79e-06	5.87e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—hematologic cancer	5.34e-06	5.41e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.26e-06	5.32e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—hematologic cancer	5.11e-06	5.17e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.98e-06	5.04e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—EP300—hematologic cancer	4.87e-06	4.93e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.83e-06	4.89e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.83e-06	4.89e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.27e-06	4.32e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—hematologic cancer	3.6e-06	3.65e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.59e-06	3.63e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.33e-06	3.37e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.15e-06	3.19e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—hematologic cancer	3.11e-06	3.15e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.98e-06	3.02e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—hematologic cancer	2.94e-06	2.98e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.75e-06	2.78e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—hematologic cancer	2.38e-06	2.41e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—EP300—hematologic cancer	2.27e-06	2.29e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.68e-06	1.7e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—hematologic cancer	1.37e-06	1.39e-05	CbGpPWpGaD
